In yesterday’s Wall Street session, Applied Therapeutics Inc (NASDAQ:APLT) shares traded at $1.15, up 0.88% from the previous session.
APLT stock price is now -84.30% away from the 50-day moving average and -80.77% away from the 200-day moving average. The market capitalization of the company currently stands at $134.98M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $13 to $2, UBS Downgraded its rating from Buy to Neutral for Applied Therapeutics Inc (NASDAQ: APLT). On November 29, 2024, RBC Capital Mkts Downgraded its previous ‘Outperform’ rating to ‘Sector Perform’ on the stock reducing its target price from $12 to quote $4, while ‘William Blair’ rates the stock as ‘Outperform’
In other news, Funtleyder Leslie D., Chief Financial Officer sold 13,530 shares of the company’s stock on Aug 22 ’24. The stock was sold for $78,880 at an average price of $5.83. Upon completion of the transaction, the Chief Financial Officer now directly owns 277,911 shares in the company, valued at $0.32 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 22 ’24, Chief Medical Officer Perfetti Riccardo sold 22,681 shares of the business’s stock. A total of $132,230 was realized by selling the stock at an average price of $5.83. This leaves the insider owning 986,853 shares of the company worth $1.13 million. A total of 25.00% of the company’s stock is owned by insiders.
During the past 12 months, Applied Therapeutics Inc has had a low of $1.12 and a high of $10.62. As of last week, the company has a debt-to-equity ratio of 0.33, a current ratio of 1.06, and a quick ratio of 1.06. The fifty day moving average price for APLT is $7.3232 and a two-hundred day moving average price translates $5.981575 for the stock.
The latest earnings results from Applied Therapeutics Inc (NASDAQ: APLT) was released for 2024-09-30.
